首页 > 市场调查报告书 > 製药

消化器

市场调查报告书

商品编码

1800961

2025 年至 2033 年胃肠治疗市场报告（按类型、给药途径、应用、配销通路和地区）

Gastrointestinal Therapeutics Market Report by Type, Route of Administration, Application, Distribution Channel, and Region 2025-2033

出版日期: 2025年08月01日 | 出版商:

IMARC | 英文 133 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

2024年全球胃肠治疗市场规模达485亿美元。展望未来， IMARC Group预计到2033年市场规模将达到718亿美元，2025-2033年期间的成长率（CAGR）为4.23%。

胃肠症候群 (GI) 是指影响消化道器官功能的疾病。它会影响胃、胰臟、小肠、大肠、胆囊和肝臟，通常以消化不良、灼热、便秘和腹胀为特征。一些常用的胃肠治疗药物包括处方药和非处方药 (OTC)，例如抗酸药、泻药、止泻药、止吐药、抗溃疡药，以及内视镜检查、放射学检查和血液学检查。这些疗法有助于发现疾病，并促进食物中营养物质的吸收，从而改善消化，调节胃肠道系统的水流量，并最大限度地降低胃酸。

发炎性肠道疾病 (IBD) 和溃疡性结肠炎等胃肠道疾病的盛行率不断上升，是推动市场成长的关键因素之一。由于生活方式的改变和不健康的饮食习惯，全球患者的疾病復发机率不断上升。此外，老年人口的不断增长也推动了市场的成长，老年人更容易患上此类疾病。各种技术进步，例如用于治疗该疾病的创新生物相似药和细胞疗法的开发，也起到了促进成长的作用。这些生物製剂透过静脉和皮下注射给药，并可根据患者的具体情况进行个人化治疗。其他因素，包括民众健康意识的增强、广泛的研发 (R&D) 活动以及医疗保健基础设施的显着改善（尤其是在发展中经济体），预计将进一步推动市场的发展。

本报告回答的关键问题：

全球胃肠治疗市场迄今表现如何？未来几年将如何表现？
COVID-19 对全球胃肠治疗市场有何影响？
主要的区域市场有哪些？
根据类型，市场区隔是怎样的？
根据行政路径，市场如何划分？
根据应用，市场细分情况如何？
根据配销通路，市场如何划分？
该产业的价值链分为哪些阶段？
该行业的主要驱动因素和挑战是什么？
全球胃肠治疗市场的结构是怎么样的？主要参与者是谁？
产业竞争程度如何？

Gastrointestinal (GI) syndrome refers to a medical ailment that affects the functioning of organs in the digestive tract. It impacts the stomach, pancreas, small and large intestines, gall bladder and liver and is usually characterized by indigestion, heartburn, constipation and bloating. Some of the commonly used GI therapeutics include prescription and over-the-counter (OTC) drugs, such as antacids, laxatives, antidiarrheal agents, antiemetics, antiulcer agents, and endoscopic and radiological procedures and hematological tests. These therapeutics assist in the detection of the disorder and absorbing nutrients from the food to improve digestion, regulate water flow in the GI system and minimize gastric acidity.

The increasing prevalence of GI diseases, such as inflammatory bowel disease (IBD) and ulcerative colitis, is one of the key factors driving the growth of the market. Due to changing lifestyle patterns and unhealthy dietary habits, there is an increased probability of disease recurrence among patients across the globe. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is also driving the market growth. Various technological advancements, such as the development of innovative biosimilars and cellular therapies for the treatment of the disorder, are acting as other growth-inducing factors. These biologics are administered through intravenous and subcutaneous injections and are personalized for targeted treatments. Other factors, including rising health consciousness among the masses, extensive research and development (R&D) activities and significant improvements in the healthcare infrastructure, especially in developing economies, are anticipated to drive the market further.

Key Market Segmentation:

Breakup by Type:

Branded
Generic

Breakup by Route of Administration:

Oral
Intravenous
Others

Breakup by Application:

Ulcerative Colitis
Crohn's Disease
GERD
Others

Breakup by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bayer Aktiengesellschaft, GlaxoSmithKline Plc, Janssen Biotech Inc. (Johnson & Johnson), Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Takeda Pharmaceuticals.

Key Questions Answered in This Report:

How has the global gastrointestinal therapeutics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global gastrointestinal therapeutics market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the application?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global gastrointestinal therapeutics market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Gastrointestinal Therapeutics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Branded
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Generic
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Route of Administration

7.1 Oral
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Intravenous
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Application

8.1 Ulcerative Colitis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Crohn's Disease
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 GERD
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

9.1 Hospital Pharmacies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Retail Pharmacies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Online Pharmacies
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 AbbVie Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 AstraZeneca Plc
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Bausch Health Companies Inc.
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Bayer Aktiengesellschaft
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 GlaxoSmithKline Plc
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Janssen Biotech Inc. (Johnson & Johnson)
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
- 15.3.8 Novo Nordisk A/S
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Pfizer Inc.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Sanofi S.A.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Takeda Pharmaceuticals
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis

简介目录图表

List of Figures

Figure 1: Global: Gastrointestinal Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Gastrointestinal Therapeutics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Gastrointestinal Therapeutics Market: Breakup by Type (in %), 2024
Figure 5: Global: Gastrointestinal Therapeutics Market: Breakup by Route of Administration (in %), 2024
Figure 6: Global: Gastrointestinal Therapeutics Market: Breakup by Application (in %), 2024
Figure 7: Global: Gastrointestinal Therapeutics Market: Breakup by Distribution Channel (in %), 2024
Figure 8: Global: Gastrointestinal Therapeutics Market: Breakup by Region (in %), 2024
Figure 9: Global: Gastrointestinal Therapeutics (Branded) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Gastrointestinal Therapeutics (Branded) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Gastrointestinal Therapeutics (Generic) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Gastrointestinal Therapeutics (Generic) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Gastrointestinal Therapeutics (Oral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Gastrointestinal Therapeutics (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Gastrointestinal Therapeutics (Intravenous) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Gastrointestinal Therapeutics (Intravenous) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Gastrointestinal Therapeutics (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Gastrointestinal Therapeutics (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Gastrointestinal Therapeutics (Ulcerative Colitis) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Gastrointestinal Therapeutics (Ulcerative Colitis) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Gastrointestinal Therapeutics (Crohn's Disease) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Gastrointestinal Therapeutics (Crohn's Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Gastrointestinal Therapeutics (GERD) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Gastrointestinal Therapeutics (GERD) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Gastrointestinal Therapeutics (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Gastrointestinal Therapeutics (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Gastrointestinal Therapeutics (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Gastrointestinal Therapeutics (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Gastrointestinal Therapeutics (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Gastrointestinal Therapeutics (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Gastrointestinal Therapeutics (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Gastrointestinal Therapeutics (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: North America: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: United States: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: United States: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Canada: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Canada: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: North America: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Asia-Pacific: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: China: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: China: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Japan: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Japan: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: India: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: India: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: South Korea: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: South Korea: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Australia: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Australia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Indonesia: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Indonesia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Asia-Pacific: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Europe: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Germany: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Germany: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: France: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: France: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: United Kingdom: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: United Kingdom: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Italy: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Italy: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Spain: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Spain: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Russia: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Russia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Europe: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Latin America: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Brazil: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Brazil: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Mexico: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Mexico: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Latin America: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Middle East and Africa: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Middle East and Africa: Gastrointestinal Therapeutics Market: Breakup by Country (in %), 2024
Figure 81: Middle East and Africa: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: Global: Gastrointestinal Therapeutics Industry: SWOT Analysis
Figure 83: Global: Gastrointestinal Therapeutics Industry: Value Chain Analysis
Figure 84: Global: Gastrointestinal Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Gastrointestinal Therapeutics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Type (in Million USD), 2025-2033
Table 3: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
Table 4: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 6: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Gastrointestinal Therapeutics Market: Competitive Structure
Table 8: Global: Gastrointestinal Therapeutics Market: Key Players

02-2729-4219

+886-2-2729-4219

License/价格

2025 年至 2033 年胃肠治疗市场报告（按类型、给药途径、应用、配销通路和地区）

Gastrointestinal Therapeutics Market Report by Type, Route of Administration, Application, Distribution Channel, and Region 2025-2033

本报告回答的关键问题：

目录

第一章：前言

第二章：范围与方法

第三章：执行摘要

第四章：简介

第五章：全球胃肠治疗市场

第六章：市场细分：依类型

第七章：市场区隔：依行政途径

第 8 章：市场区隔：按应用

第九章：市场区隔：按配销通路

第十章：市场细分：按地区

第 11 章：SWOT 分析

第 12 章：价值链分析

第 13 章：波特五力分析

第 14 章：价格分析

第 15 章：竞争格局